PhRMA member companies are taking individual steps to build trust and encourage broader, more diverse clinical trial participation. A recent survey of many PhRMA members found 97% of respondents reported specific measures they’re taking to address access issues for clinical trial participants. In the pages of this report, you’ll find dozens of case studies covering this work.